Literature DB >> 24528342

Intestinal permeability measurements: general aspects and possible pitfalls.

Tatiana Fiche Salles Teixeira1, Ana Paula Boroni Moreira1, Nilian Carla Silva Souza2, Rafael Frias3, Maria do Carmo Gouveia Peluzio1.   

Abstract

INTRODUCTION: Disturbances of the gut barrier function have been related to a variety of diseases, including intestinal and extra-intestinal diseases. The intestinal permeability tests are considered useful tools for evaluating disease severity and to follow-up patients after a therapeutic intervention and indirectly assess barrier function.
OBJECTIVE: The aims of this review were to highlight the possible factors underlying higher intestinal permeability and the clinical conditions that have been associated with this in different age range; and also provide some insight into methodological aspects. RESULTS AND DISCUSSION: Abnormal regulation of tight junction function is the main cause of altered intestinal barrier. The impaired barrier function results in higher permeation rates of administered probes through the intestinal mucosa. Lactulose and mannitol are one of the most commonly used probes. The innocuousness and easiness of intestinal permeability tests can be explored to expand the knowledge about the clinical situations in which intestinal barrier dysfunction can be an important feature. Many factors may influence the results of the test. Researchers and healthcare professionals should try to circumvent the possible pitfalls of the intestinal permeability tests to produce consistent evidences. The use of others markers of intestinal physiology may also contribute to understand the role of barrier function in different diseases. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24528342     DOI: 10.3305/nh.2014.29.2.7076

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  5 in total

1.  Ceftriaxone causes dysbiosis and changes intestinal structure in adjuvant obesity treatment.

Authors:  Sandra Aparecida Dos Reis Louzano; Mariana de Moura E Dias; Lisiane Lopes da Conceição; Tiago Antônio de Oliveira Mendes; Maria do Carmo Gouveia Peluzio
Journal:  Pharmacol Rep       Date:  2021-11-10       Impact factor: 3.024

2.  A Simple, Robust, and Convenient HPLC Assay for Urinary Lactulose and Mannitol in the Dual Sugar Absorption Test.

Authors:  Ivana R Sequeira; Marlena C Kruger; Roger D Hurst; Roger G Lentle
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

3.  Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Enea Bonci; Lidia Marandola; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

4.  The Gut Mucosal Firewall and Functional Medicine.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-08

5.  Real-time Measurement of Epithelial Barrier Permeability in Human Intestinal Organoids.

Authors:  David R Hill; Sha Huang; Yu-Hwai Tsai; Jason R Spence; Vincent B Young
Journal:  J Vis Exp       Date:  2017-12-18       Impact factor: 1.355

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.